| Literature DB >> 28398513 |
Eythor Bjornsson1,2, Hannes Helgason1,3, Gisli Halldorsson1, Anna Helgadottir1,2, Arnaldur Gylfason1, Birte Kehr1, Adalbjorg Jonasdottir1, Aslaug Jonasdottir1, Asgeir Sigurdsson1, Asmundur Oddsson1, Gudmar Thorleifsson1, Olafur Th Magnusson1, Solveig Gretarsdottir1, Florian Zink1, Ragnar P Kristjansson1, Margret Asgeirsdottir1, Dorine W Swinkels4, Lambertus A Kiemeney5, Gudmundur I Eyjolfsson6, Olof Sigurdardottir7, Gisli Masson1, Isleifur Olafsson8, Gudmundur Thorgeirsson2,9, Hilma Holm1,9, Unnur Thorsteinsdottir1,2, Daniel F Gudbjartsson1,3, Patrick Sulem1, Kari Stefansson1,2.
Abstract
Common sequence variants at the haptoglobin gene (HP) have been associated with blood lipid levels. Through whole-genome sequencing of 8,453 Icelanders, we discovered a splice donor founder mutation in HP (NM_001126102.1:c.190 + 1G > C, minor allele frequency = 0.56%). This mutation occurs on the HP1 allele of the common copy number variant in HP and leads to a loss of function of HP1. It associates with lower levels of haptoglobin (P = 2.1 × 10-54), higher levels of non-high density lipoprotein cholesterol (β = 0.26 mmol/l, P = 2.6 × 10-9) and greater risk of coronary artery disease (odds ratio = 1.30, 95% confidence interval: 1.10-1.54, P = 0.0024). Through haplotype analysis and with RNA sequencing, we provide evidence of a causal relationship between one of the two haptoglobin isoforms, namely Hp1, and lower levels of non-HDL cholesterol. Furthermore, we show that the HP1 allele associates with various other quantitative biological traits.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28398513 DOI： 10.1093/hmg/ddx123
Source DB: PubMed Journal: Hum Mol Genet ISSN： 0964-6906 Impact factor: 6.150